← Leaderboards
Anna-Barbara None Moscicki
University Of California San Francisco
$36,508,762
Attributed
$37,624,829
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,624,829 · 14
By mechanism
R37$15,443,312 · 1
R01$14,242,780 · 4
U01$7,046,043 · 3
RC1$497,858 · 1
P01$292,167 · 1
M01$102,669 · 4
Top collaborators
- Loris Y. Hwang3 shared
Most similar at University Of California San Francisco
Same institution · by research overlap
- Katherine Kurshan Matthay$7,757,759
- James L. Sorensen$27,892,556
- Frank Patrick McCormick$56,513,144
- Diane W. Wara$7,985,315
- John Kurhanewicz$27,913,734
Others in their field
Top investigators on “Human Papillomavirus”
- Ronald T Mitsuyasu · University Of California Los Angeles$106,431,894
- Leonard Freedman · Leidos Biomedical Research, Inc.$53,948,093
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$50,130,116
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- David Heimbrook · Leidos Biomedical Research, Inc.$33,306,253
- Paul F Lambert · University Of Wisconsin Madison$31,091,618
Research focus
Human PapillomavirusHuman SubjectAdolescence (12-20)Longitudinal Human StudyWomanCervicalSamplingCytologyClinical ResearchAdolescentInfectionVaccinesCohortNatural HistoryFemalePolymerase Chain ReactionVisitCervix NeoplasmsCytotoxic T LymphocyteHiv InfectionsProspectiveHuman Papillomavirus 16Sex BehaviorCytokine
Grant awards (60)
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies$109,771
R01 · FY2025 · CA · contact PI
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies$904,785
R01 · FY2024 · CA · contact PI
Natural History of CIN and HPV in HPV Vaccinated Youth with PHIV$54,343
P01 · FY2024 · HD · contact PI
Real-world effectiveness of HPV vaccine in women living with HIV and its impact on cervical cancer screening accuracies$1,095,428
R01 · FY2023 · CA · contact PI
Natural History of CIN and HPV in HPV Vaccinated Youth with PHIV$54,332
P01 · FY2023 · HD · contact PI
Natural History of CIN and HPV in HPV Vaccinated Youth with PHIV$57,305
P01 · FY2022 · HD · contact PI
Natural History of CIN and HPV in HPV Vaccinated Youth with PHIV$55,395
P01 · FY2021 · HD · contact PI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity$680,407
R01 · FY2020 · AI
Natural History of CIN and HPV in HPV Vaccinated Youth with PHIV$70,792
P01 · FY2020 · HD · contact PI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity$782,960
R01 · FY2019 · AI
Biological Vulnerability to Chlamydia trachomatis in Adolescents and Young Women: the Complex Intersection of Cervicovaginal Microbiome, Cervical Maturation, and Mucosal Immunity$768,767
R01 · FY2018 · AI
Natural History of HPV Infection to Neoplasia$848,301
R37 · FY2014 · CA · contact PI
Natural History of HPV Infection to Neoplasia$569,400
R37 · FY2014 · CA · contact PI
Natural History of HPV Infection to Neoplasia$1,399,693
R37 · FY2013 · CA · contact PI
Natural History of HPV Infection to Neoplasia$1,528,615
R37 · FY2012 · CA · contact PI
Natural History of HPV Infection to Neoplasia$1,562,921
R37 · FY2011 · CA · contact PI
Natural History of HPV Infection to Neoplasia$1,638,032
R37 · FY2010 · CA · contact PI
A San Francisco Street Youth Cohort: At Risk and HIV+$854,879
U01 · FY2010 · HD · contact PI
Mucosal immune response of the anus in women to HPV, intercourse, smoking and OCs$497,858
RC1 · FY2010 · AI · contact PI
Natural History of HPV Infection to Neoplasia$1,580,769
R37 · FY2009 · CA · contact PI
A San Francisco Street Youth Cohort: At Risk and HIV+$875,049
U01 · FY2009 · HD · contact PI
Natural History of HPV Infection to Neoplasia$140,901
R37 · FY2009 · CA · contact PI
Natural History of HPV Infection to Neoplasia$1,532,397
R37 · FY2008 · CA · contact PI
A San Francisco Street Youth Cohort: At Risk and HIV+$851,604
U01 · FY2008 · HD · contact PI
Natural History of HPV Infection to Neoplasia$1,543,996
R37 · FY2007 · CA · contact PI
A San Francisco Street Youth Cohort: At Risk and HIV+$675,198
U01 · FY2007 · HD · contact PI
Natural History of CIN2 in Adolescents$268,000
R01 · FY2007 · CA · contact PI
Natural History of HPV Infection to Neoplasia$1,539,852
R37 · FY2006 · CA · contact PI
A San Francisco Street Youth Cohort: At Risk and HIV+$374,113
U01 · FY2006 · HD · contact PI
Natural History of HPV Infection to Neoplasia$1,558,435
R37 · FY2005 · CA
Natural History of CIN2 in Adolescents$740,043
R01 · FY2005 · CA
A SAN FRANCISCO STREET YOUTH COHORT: AT-RISK AND HIV+$515,813
U01 · FY2005 · HD
NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS FROM INFECTION TO NEOPLASIA$40,366
M01 · FY2005 · RR
METABOLIC ABNORMALITIES IN HIV-INFECTED AND UNINFECTED YOUNG WOMEN$12,481
M01 · FY2005 · RR
HEPATITIS B VACCINATION AND TOOLS TO BE USED IN FUTURE HIV PREVENTION TRIALS$3,791
M01 · FY2005 · RR
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA$1,256,014
R01 · FY2004 · CA
Natural History of CIN2 in Adolescents$746,297
R01 · FY2004 · CA
A SAN FRANCISCO STREET YOUTH COHORT: AT-RISK AND HIV+$695,385
U01 · FY2004 · HD
Natural history of HPV from infection to neoplasia in young women$20,232
M01 · FY2004 · RR
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA$1,222,379
R01 · FY2003 · CA
Natural History of CIN2 in Adolescents$767,513
R01 · FY2003 · CA
A SAN FRANCISCO STREET YOUTH COHORT: AT-RISK AND HIV+$717,388
U01 · FY2003 · HD
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA$1,189,723
R01 · FY2002 · CA
Natural History of CIN2 in Adolescents$767,984
R01 · FY2002 · CA
A SAN FRANCISCO STREET YOUTH COHORT: AT-RISK AND HIV+$736,388
U01 · FY2002 · HD
Immunologic Correlates of Initial Cervical HPV Infection$0
U01 · FY2002 · AI
NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS FROM INFECTION TO NEOPLASIA$0
M01 · FY2002 · RR
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA$1,157,602
R01 · FY2001 · CA
Natural History of CIN2 in Adolescents$651,641
R01 · FY2001 · CA
ADOLESCENT MEDICINE TRIAL NETWORK FOR HIV/AIDS$252,068
U01 · FY2001 · HD
ADOLESCENT MEDICINE HIV/AIDS RESEARCH NETWORK$181,022
U01 · FY2001 · HD
Immunologic Correlates of Initial Cervical HPV Infection$0
U01 · FY2001 · AI
Immunologic Correlates of Initial Cervical HPV Infection$0
U01 · FY2001 · AI
NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS FROM INFECTION TO NEOPLASIA$0
M01 · FY2001 · RR
NATURAL HISTORY OF HPV--INFECTION TO NEOPLASIA$1,133,466
R01 · FY2000 · CA
ADOLESCENT MEDICINE HIV/AIDS RESEARCH NETWORK$171,304
U01 · FY2000 · HD
Immunologic Correlates of Initial Cervical HPV Infection$145,832
U01 · FY2000 · AI
NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS FROM INFECTION TO NEOPLASIA$25,799
M01 · FY2000 · RR
NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS FROM INFECTION TO NEOPLASIA$0
M01 · FY2000 · RR
NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS FROM INFECTION TO NEOPLASIA$0
M01 · FY2000 · RR